Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT00001645 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Evaluation, Treatment and Monitoring of Patients With a Known or Suspected Parasitic Infection

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

The 50 most recent of 388 record versions are accounted for below. See every version on ClinicalTrials.gov ↗

  1. Re-verified, no change to tracked fields
  2. Re-verified, no change to tracked fields
  3. New version filed on ClinicalTrials.gov
  4. 12 versions Re-verified since Dec 16, 2025, no change to tracked fieldsv374-v385
  5. Enrollment target: 500 to 800v373
  6. 34 versions Re-verified since Dec 20, 2024, no change to tracked fieldsv339-v372
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of this study is to evaluate, treat and follow patients with parasitic infections. People with a known or suspected parasitic infection who are at least 1 year old may be enrolled. This study does not involve any experimental treatments. Participants will have a physical examination and laboratory tests on blood, stool, or urine. Blood samples may be collected at regular intervals, but no more than 450 ml (15 ounces) of blood will be drawn from adults, and no more than 7 ml (1-1/2 teaspoons) per kg (2.2 pounds) of body weight from children, in any 6-week period. Other tests may include x-rays, electrocardiogram (EKG), or tissue biopsy (surgical removal of a small tissue sample), depending on the individual s condition. Patients may be offered treatment or may be referred to another study that is more appropriate for the problem. Any treatment provided in this study will be according to standard medical practice for the patient s specific medical problem. Patients responses to treatment will be evaluated at regularly scheduled clinic visits. The length of time between visits and the total duration of the study for a given individual will be determined by the study doctor, based on that person s medical condition.
Trial Details
NCT Number NCT00001645
Lead Sponsor National Institute of Allergy and Infectious Diseases (NIAID)
Conditions Malaria, Intestinal Worms, GI Protozoa, Echiniococcus, Strongyloides
Enrollment 800 participants
Start Date
Updated on ClinicalTrials.gov